Pfizer Inc. plans to spend billions of dollars to join the race for a new type of cancer treatment. Similar to its competitors, Pfizer also plans to partner with a Chinese company. The company PFE ...

Amneal Pharmaceuticals is recalling three lots of sulfamethoxazole/trimethoprim tablets because of microbial contamination that caused black spots to appear on the ...

The country’s medicines regulator has approved the use of a GLP-1 weight-loss drug to treat people with sleep apnoea for the first time, broadening the applications for the popular drugs beyond ...

Doctor explains how a new drug could improve quality of life for autistic children Rheumatologist Dr. Mahsa Tehrani weighs in on a potential treatment for autism and discusses the risks of using ...

The study included patients with R/R multiple myeloma who had progressed after at least 3 prior lines of therapy, including a proteasome inhibitor, an immunomodulatory drug, and an anti-CD38 ...

But like every drug, they have their possible trade-offs, including muscle loss. The Truth About Ozempic and Muscle Loss Experts have correctly argued that this side effect isn’t truly unique to ...

Salazar said deputies discovered a wounded 16-year-old boy who had been shot in an suspected drug deal gone wrong. Investigators said the young man had met with the suspects to sell THC vapes when ...

Biocon has secured Indian regulatory approval for its generic Liraglutide drug substance and product, a version of Victoza, for treating Type 2 Diabetes in adults and children over 10. CEO Siddharth ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy.

In December, the U.S. Food and Drug Administration (FDA) approved a new treatment for people with insomnia, Dayvigo (lemborexant). The drug will be available in 5 or 10 milligram (mg) doses ...

Between 1995 and 2021 private money spent on Alzheimer’s research came to $42.5bn, but more than 140 trials failed to yield a single drug capable of slowing the disease. Yet the tide may be turning.